Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Boelaert

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Acta Clinica Belgica|January 1, 1996
Iron and infectionJ R Boelaert
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a reviewJ R Boelaert
The Journal of Infection|May 1, 1994
Mucormycosis (zygomycosis): is there news for the clinician?J R Boelaert
The American Journal of Medicine|June 1, 1986
Exogenous protein as the cause of nephrotic-range proteinuriaJ R Boelaert
The Journal of Infectious Diseases|September 9, 1999
Cryptococcosis and smoking: the potential role of ironJ R Boelaert, E Blasi
Lancet (London, England)|October 20, 1998
Antiretroviral treatmentJ R Boelaert, K Sperber
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Side-effects of desferrioxamine in dialysis patientsJ R Boelaert, M de Locht
Kidney International|December 1, 1989
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)J Van Cutsem, J R Boelaert
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
The potential place of chloroquine in the treatment of HIV-1-infected patientsJ R Boelaert, J Piette, K Sperber
Biochemical Pharmacology|May 30, 2001
The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyureaJ R Boelaert, K Sperber, J Piette
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Acta Clinica Belgica|January 1, 1996
Iron and infectionJ R Boelaert
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a reviewJ R Boelaert
The Journal of Infection|May 1, 1994
Mucormycosis (zygomycosis): is there news for the clinician?J R Boelaert
The American Journal of Medicine|June 1, 1986
Exogenous protein as the cause of nephrotic-range proteinuriaJ R Boelaert
The Journal of Infectious Diseases|September 9, 1999
Cryptococcosis and smoking: the potential role of ironJ R Boelaert, E Blasi
Lancet (London, England)|October 20, 1998
Antiretroviral treatmentJ R Boelaert, K Sperber
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1993
Side-effects of desferrioxamine in dialysis patientsJ R Boelaert, M de Locht
Kidney International|December 1, 1989
Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)J Van Cutsem, J R Boelaert
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 13, 2001
The potential place of chloroquine in the treatment of HIV-1-infected patientsJ R Boelaert, J Piette, K Sperber
Biochemical Pharmacology|May 30, 2001
The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyureaJ R Boelaert, K Sperber, J Piette
Pageof 10